Jefferies analyst Johnson Wan downgrades XPeng (NYSE:XPEV) from Hold to Underperform and lowers the price target from $18.6 to $4.2.
Expert Ratings For Amgen
In the latest quarter, 11 analysts provided ratings for Amgen (NASDAQ:AMGN), showcasing a mix of bullish and bearish…